Search Within

Larry Norton

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (95)
  2. Meeting Abstract (87)
  3. Editorial (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (184)
  2. Breast Medicine Service (184)
  3. Department of Medicine (184)
  4. Population Sciences Research Program (184)
  5. Solid Tumor Oncology Division (184)
  6. Survivorship Research (172)

More Groups

People
  1. Clifford Hudis (96)
  2. Mark Robson (89)
  3. Chau Dang (55)
  4. Katherine Panageas (47)
  5. Kenneth Offit (45)
  6. Maura Dickler (34)

More People

Years
  1. 2024 (8)
  2. 2023 (6)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (12)
  6. 2019 (13)

More Years

Publications
  1. Journal of Clinical Oncology (49)
  2. Breast Cancer Research and Treatment (22)
  3. Cancer Research (17)
  4. Clinical Cancer Research (12)
  5. Laboratory Investigation (7)
  6. American Journal of Human Genetics (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. American Association for Cancer Research (34)
  3. Springer (23)
  4. Nature Publishing Group (19)
  5. Oxford University Press (10)
  6. Cell Press (8)

More Publishers

Results (184)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center
    Meeting Abstract

    Fontes Santos De Teive Argolo, D.; Smyth, L. M.; Iyengar, N. M.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Metastatic breast carcinomas display genomic and transcriptomic heterogeneity
    Journal Article

    Weigelt, B.; Ng, C. K. Y.; Shen, R.; Popova, T.; Schizas, M.; Natrajan, R.; Mariani, O.; Stern, M. H.; Norton, L.; Vincent-Salomon, A.; more...
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Clinicopathologic features of preinvasive and microinvasive breast lesions in BRCA germline mutation carriers
    Meeting Abstract

    Sebastiano, C.; Wen, Y. H.; Martinez, J.; Bowser, Z.; Akram, M.; Norton, L.; Robson, M.; Reis-Filho, J.; Brogi, E.
    Modern Pathology (2015)

    Fulltext@MSK | Save
  • Clinicopathologic features of preinvasive and microinvasive breast lesions in BRCA germline mutation carriers
    Meeting Abstract

    Sebastiano, C.; Wen, Y. H.; Martinez, J.; Bowser, Z.; Akram, M.; Norton, L.; Robson, M.; Reis-Filho, J.; Brogi, E.
    Laboratory Investigation (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations
    Journal Article

    Martelotto, L. G.; Ng, C. K.; De Filippo, M. R.; Zhang, Y.; Piscuoglio, S.; Lim, R. S.; Shen, R.; Norton, L.; Reis-Filho, J. S.; Weigelt, B.
    Genome Biology (2014)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Determination of cancer susceptibility in probands with breast and ovarian cancer
    Meeting Abstract

    Schrader, K. A.; Maxwell, K. N.; Vijai, J.; Hart, S.; Thomas, T.; Wubbenhorst, B.; Guidugli, L.; Klein, R.; Corines, M.; Zhang, L.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save